LGHT
Langar Global HealthTech ETF
NAV as of
4 Week: 8.51 - 9.02
52 Week: 8.51 - 10.66
Latest Closing Price
8.83
Premium / Discount
0.14
Expense Ratio
0.85%
Investment Objective
The investment seeks long-term growth of capital. Under normal circumstances, the fund will invest at least 80% of the fund’s net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts (“ADRs”) on those securities. These securities may be of any market capitalization. The fund is non-diversified.
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | -11.65 | 1.24 | -9.39 |
| 1 Day | -1.89 | 0.00 | 0.00 |
| 1 Week | -0.79 | 3.01 | -0.26 |
| 1 Month | 0.26 | 5.73 | 0.04 |
| 3 Months | -14.00 | 9.89 | -1.41 |
| 6 Months | -14.94 | 12.59 | -1.19 |
| 1 Year | -2.64 | 17.77 | -0.15 |
| 2 Years | -11.49 | 26.35 | -0.44 |
| 3 Years | 0.00 | 0.00 | 0.00 |
| 5 Years | 0.00 | 0.00 | 0.00 |
| 10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
| Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | -1.5129 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 100.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| N.A | ||
Portfolio Data
Total Number of Holdings: 30
Number of Bond Holdings: 0
Number of Equity Holdings: 29
Total Market Value: 3,601,156
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | Intuitive Surgical Inc | 12.9428 | 1,001 | 0 | 466,066 |
| 2 | ResMed Inc | 11.7185 | 1,866 | 0 | 421,977 |
| 3 | GE HealthCare Technologies Inc Common Stock | 7.9155 | 3,844 | 0 | 285,033 |
| 4 | Insulet Corp | 7.3912 | 1,325 | 0 | 266,153 |
| 5 | Moderna Inc | 6.9280 | 4,570 | 0 | 249,476 |
| 6 | Veeva Systems Inc Class A | 6.6815 | 1,425 | 0 | 240,597 |
| 7 | Koninklijke Philips NV ADR | 6.2628 | 7,726 | 0 | 225,522 |
| 8 | IQVIA Holdings Inc | 5.7432 | 1,170 | 0 | 206,809 |
| 9 | Zimmer Biomet Holdings Inc | 4.3723 | 1,649 | 0 | 157,447 |
| 10 | DexCom Inc | 4.0431 | 2,253 | 0 | 145,589 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 0.00 |
| Large | 22.69 |
| Medium | 58.71 |
| Small | 9.54 |
| Micro | 3.95 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
19.3499
Price/Book*
3.5347
Price/Sales*
2.7977
Price/Cash Flow*
13.5235
Dividend Yield*
0.6586
Growth Measures
Long-Term Earnings
9.9638
Historical Earnings
12.5974
Sales Growth
3.2038
Cash-Flow Growth
20.3751
Book-Value Growth
1.4078
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
